EE506 RNA Interference Therapies for hATTR Amyloidosis With Polyneuropathy: Differential Healthcare Resource Use and Direct and Indirect Cost Consequences Associated With Vutrisiran Versus Patisiran
Abstract
Authors
V. Kumar N. Kotsopoulos M. Connolly D. Danese